Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations

PaperCitations, authors & open-access status

Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,325 citations, 2018 year and gold oa status.

1,325
Citations
2018
Year
gold
OA Status

Related on ScholarIQ

Ravi Salgia
Author
Cancer Immunotherapy and Biomarkers
Topic
Cancer Immunotherapy and Biomarkers
Topic
Pancreatic and Hepatic Oncology Research
Topic
CAR-T cell therapy research
Topic
470M+ articles · free account